These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 31584877
1. CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma. Zhao R, Ni J, Lu S, Jiang S, You L, Liu H, Shou J, Zhai C, Zhang W, Shao S, Yang X, Pan H, Han W. Aging (Albany NY); 2019 Oct 04; 11(19):8484-8501. PubMed ID: 31584877 [Abstract] [Full Text] [Related]
3. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma. Wang WJ, Li HT, Yu JP, Han XP, Xu ZP, Li YM, Jiao ZY, Liu HB. J Surg Res; 2019 Mar 04; 235():22-33. PubMed ID: 30691798 [Abstract] [Full Text] [Related]
9. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers. Kong X, Qi J, Yan Y, Chen L, Zhao Y, Fang Z, Fan J, Liu M, Liu Y. J Cell Biochem; 2019 Oct 04; 120(10):17963-17974. PubMed ID: 31127661 [Abstract] [Full Text] [Related]
10. Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis. Sun X, Ge X, Xu Z, Chen D. J Gastroenterol Hepatol; 2020 Jan 04; 35(1):157-164. PubMed ID: 31222831 [Abstract] [Full Text] [Related]
11. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma. Yuan Q, Ren J, Li L, Li S, Xiang K, Shang D. Bioengineered; 2021 Dec 04; 12(1):2432-2448. PubMed ID: 34233576 [Abstract] [Full Text] [Related]
14. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Guo Y, Wang R, Li J, Song Y, Min J, Zhao T, Hua L, Shi J, Zhang C, Ma P, Yang C, Zhu L, Gan D, Li S, Liu X, Su H. Front Immunol; 2021 Dec 04; 12():769425. PubMed ID: 34804059 [Abstract] [Full Text] [Related]
15. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma. Li L, Xiao Z, He P, Zou W, Deng Z, Zhang G, Liu R. BMC Gastroenterol; 2022 Nov 12; 22(1):454. PubMed ID: 36371178 [Abstract] [Full Text] [Related]
16. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis. Du W, Lei C, Wang Y, Ding Y, Tian P. Technol Cancer Res Treat; 2021 Nov 12; 20():1533033820988525. PubMed ID: 33506742 [Abstract] [Full Text] [Related]
18. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma. Shi T, Gao G. Biosci Rep; 2022 Feb 25; 42(2):. PubMed ID: 35083488 [Abstract] [Full Text] [Related]
19. TCGA dataset‑based construction and integrated analysis of aberrantly expressed long non‑coding RNA mediated competing endogenous RNA network in gastric cancer. He W, Zhang D, Li X, Wu J, Yang X, Wang Q, Lu W, Jiang J, Wu C. Oncol Rep; 2018 Dec 25; 40(6):3511-3522. PubMed ID: 30272352 [Abstract] [Full Text] [Related]